Endometrial Receptivity Analysis (ERA) evaluates the status of the woman’s endometrial receptivity to prevent implantation failure. Diagnostic technique patented* by IGENOMIX that identifies the patient’s unique “window of implantation” leading to a personalized embryo transfer (pET) based on the individual results obtained. 24% of ERA patients are non-receptive. In 88% of cases, a second endometrial biopsy will determine the window of implantation and therefore the period in which the patient is receptive.
Learn more about Endometrial Receptivity Analysis.